ArticlePLoS pathogens2024

Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses.

Zuxin Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.